Home » Stocks » VERO

Venus Concept Inc. (VERO)

Stock Price: $2.47 USD -0.02 (-0.80%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
Market Cap 133.55M
Revenue (ttm) 86.10M
Net Income (ttm) -47.90M
Shares Out 54.07M
EPS (ttm) -1.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $2.47
Previous Close $2.49
Change ($) -0.02
Change (%) -0.80%
Day's Open 2.47
Day's Range 2.35 - 2.48
Day's Volume 80,425
52-Week Range 1.60 - 3.44

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medi...

4 days ago - GlobeNewsWire

TORONTO, July 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will partic...

1 week ago - GlobeNewsWire

TORONTO, July 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that second quarter of fiscal yea...

2 weeks ago - GlobeNewsWire

TORONTO, May 17, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three mo...

2 months ago - GlobeNewsWire

Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Venus Concept (VERO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

2 months ago - Zacks Investment Research

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that first quarter of fiscal yea...

3 months ago - GlobeNewsWire

Venus Concept (VERO) delivered earnings and revenue surprises of -37.50% and 0.51%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shares of Venus Concept (NASDAQ:VERO) increased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 74.77% over the past year to ($0.27), which misse...

3 months ago - Benzinga

TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three ...

3 months ago - GlobeNewsWire

Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will atten...

4 months ago - GlobeNewsWire

TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will partic...

5 months ago - GlobeNewsWire

TORONTO, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal ye...

5 months ago - GlobeNewsWire

TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenu...

6 months ago - GlobeNewsWire

TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will partic...

6 months ago - GlobeNewsWire

TORONTO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (Nasdaq: VERO), a global medical aesthetic technology leader, today announced the pricing of its public o...

7 months ago - GlobeNewsWire

TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it intends to offer an...

7 months ago - GlobeNewsWire

New loan and debt exchange agreements significantly enhance balance sheet and financial condition by lowering overall cost of borrowing, reducing annual interest expense and improving future cash flow N...

7 months ago - GlobeNewsWire

TORONTO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Company will host ...

7 months ago - GlobeNewsWire

Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Venus Concept (VERO) delivered earnings and revenue surprises of 25.00% and -21.84%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

Shares of Venus Concept (NASDAQ:VERO) moved higher by 3.9% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 82.35% over the past year to ($0.18), wh...

8 months ago - Benzinga

TORONTO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three a...

8 months ago - GlobeNewsWire

TORONTO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will partic...

8 months ago - GlobeNewsWire

TORONTO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of fiscal year...

9 months ago - GlobeNewsWire

Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Venus Concept (VERO) delivered earnings and revenue surprises of -8.33% and 2.70%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

TORONTO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three...

11 months ago - GlobeNewsWire

Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

11 months ago - Zacks Investment Research

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary revenue result...

1 year ago - GlobeNewsWire

Venus Viva MD is a new skin rejuvenation solution with differentiated features that allow clinicians in the traditional medical aesthetics community to treat a wider range of skin conditions Venus Viva ...

1 year ago - GlobeNewsWire

TORONTO, June 26, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Company has been...

1 year ago - GlobeNewsWire

Forget undervalued stocks, play these top-ranked stocks with rising P/E.

Other stocks mentioned: JAGX, SNCR, STNG
1 year ago - Zacks Investment Research

TORONTO, June 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into ...

1 year ago - GlobeNewsWire

Venus Epileve is a new, cost-effective, laser hair removal solution designed for customers in the aesthetics market Venus Epileve is a new, cost-effective, laser hair removal solution designed for custo...

1 year ago - GlobeNewsWire

Venus Concept Inc. (VERO) CEO Domenic Serafino on Q2 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Venus Concept (VERO) delivered earnings and revenue surprises of -14.12% and -13.54%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

TORONTO, May 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three ...

1 year ago - GlobeNewsWire

Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Venus Concept Inc. (VERO) CEO Domenic Serafino on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

TORONTO, March 18, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it entered into a d...

1 year ago - GlobeNewsWire

Chad A. Zaring, Appointed Chief Commercial Officer Chad A. Zaring, Appointed Chief Commercial Officer

1 year ago - GlobeNewsWire

TORONTO, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received CE M...

1 year ago - GlobeNewsWire

TORONTO, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced preliminary unaudited rev...

Other stocks mentioned: HAIR
1 year ago - GlobeNewsWire

About VERO

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Velocity and Venus Epileve, a diode laser device for hair removal, permanent hair reduction, and trea... [Read more...]

Industry
Medical Devices
CEO
Domenic Serafino
Employees
384
Stock Exchange
NASDAQ
Ticker Symbol
VERO
Full Company Profile

Financial Performance

In 2020, Venus Concept's revenue was $78.01 million, a decrease of -29.34% compared to the previous year's $110.41 million. Losses were -$85.27 million, 109.9% more than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for Venus Concept stock is "Buy." The 12-month stock price forecast is 5.50, which is an increase of 122.67% from the latest price.

Price Target
$5.50
(122.67% upside)
Analyst Consensus: Buy